Ceramide Concentration: What Your Barrier Cream Actually Contains

Ceramides are the structural lipids of the skin barrier. They make up approximately 50% of the lipid content of the stratum corneum, forming the "mortar" between the corneocyte "bricks" that constitute the skin's outermost protective layer. When ceramide levels are depleted — through ageing, harsh cleansing, over-exfoliation, or conditions like eczema — the skin barrier becomes compromised, leading to increased transepidermal water loss, sensitivity, and susceptibility to irritants and allergens.

The clinical evidence for ceramide supplementation in compromised skin is strong. Products containing ceramides have been shown to improve barrier function, reduce TEWL, and alleviate symptoms of atopic dermatitis in multiple independent studies. The ingredient works. The question is whether the ceramide products most consumers buy contain enough ceramide to do anything.

The Ceramide Family

"Ceramide" is not a single ingredient — it is a class of lipid molecules. The skin contains at least 12 distinct ceramide subclasses, identified by the nature of their fatty acid and sphingoid base components. The most clinically relevant ceramides in skincare are:

Ceramide NP (formerly Ceramide 3) — the most abundant ceramide in the stratum corneum. Well-studied for barrier repair.

Ceramide AP (formerly Ceramide 6-II) — present in significant quantities in the stratum corneum. Important for lamellar body secretion.

Ceramide EOP (formerly Ceramide 1) — the most critical ceramide for barrier function. Present at lower concentrations than NP and AP but plays a key structural role in the lamellar bilayer.

Ceramide NS (formerly Ceramide 2) — present in the stratum corneum and important for barrier integrity.

The INCI names for ceramides changed in 2006 when the INCI nomenclature was updated to a more systematic naming convention. The old names (Ceramide 1, 2, 3, 6-II) are still used in some product marketing and older literature; the new names (Ceramide EOP, NS, NP, AP) are the current INCI standard.

"A product listing 'Ceramide NP' at the end of its INCI list, after the preservative and fragrance, contains ceramide at a concentration that may be insufficient to meaningfully support barrier function. The ingredient is present. Whether it is present at a therapeutically relevant concentration is a different question."

The Concentration Problem

The effective concentration of ceramides in skincare products is a subject of ongoing research. The clinical studies demonstrating ceramide efficacy for barrier repair and atopic dermatitis typically use products with ceramide concentrations in the range of 0.2–5% total ceramides.

Commercial skincare products vary enormously in their ceramide content. A product that lists Ceramide NP near the end of its INCI list — after Phenoxyethanol (typically 0.5–1%) — contains ceramide at below 1%, likely at 0.01–0.1%. This may be insufficient to replicate the effects demonstrated in clinical studies.

The challenge for consumers is that ceramide concentrations are almost never disclosed on product labels. Unlike niacinamide (where "5% Niacinamide" is a common label claim) or vitamin C (where "15% Vitamin C" is standard), ceramide concentrations are rarely specified. A product can market itself as a "ceramide-rich barrier repair cream" while containing trace amounts of ceramide.

The Ratio Question

Research on skin ceramide composition has found that the ratio of ceramide subtypes matters, not just the total concentration. The natural stratum corneum contains ceramides in a specific ratio — approximately 3:1:1 of ceramide NP:AP:EOP (with variations across individuals and skin conditions).

A 2022 analysis of commercial ceramide products found that many did not replicate the natural ceramide ratio. Some products contained only a single ceramide subtype. Others contained ceramides in ratios that did not reflect the natural stratum corneum composition.

The clinical significance of ceramide ratio in topical products is not fully established — the skin may be able to utilise individual ceramide subtypes regardless of ratio. But the marketing claim that a product "mimics the skin's natural ceramide ratio" requires that the product actually contain ceramides in that ratio, at concentrations sufficient to contribute meaningfully to the stratum corneum.

Pseudoceramides and Ceramide Alternatives

Several cosmetic ingredients are marketed as ceramide alternatives or ceramide-like molecules:

Phytosphingosine (INCI: Phytosphingosine) — a sphingoid base that is a precursor to ceramide synthesis in skin. It does not provide ceramides directly but may stimulate the skin's own ceramide production. Well-studied for acne and sensitive skin applications.

Sphingosine (INCI: Sphingosine) — another sphingoid base with antimicrobial and anti-inflammatory properties.

Cholesterol (INCI: Cholesterol) — not a ceramide, but a critical component of the stratum corneum lipid bilayer. Products that combine ceramides with cholesterol and fatty acids (particularly Palmitic Acid and Linoleic Acid) more closely replicate the complete lipid composition of the stratum corneum.

Pseudoceramides — synthetic molecules designed to mimic ceramide structure and function. Cetyl-PG Hydroxyethyl Palmitamide is a commonly used pseudoceramide. The evidence for their efficacy is generally positive but less extensive than for natural ceramides.

What to Look For

When evaluating a ceramide product:

Multiple ceramide subtypes — a product listing Ceramide NP, Ceramide AP, and Ceramide EOP (or their older equivalents) is more likely to provide meaningful barrier support than a product with a single ceramide.

Position in the INCI list — ceramides should appear in the first half of the list for a product making significant barrier repair claims. Ceramides appearing after the preservative system are present at very low concentrations.

Complete lipid system — the most effective barrier repair products combine ceramides with Cholesterol and fatty acids (Palmitic Acid, Linoleic Acid, Stearic Acid). This combination more closely replicates the natural stratum corneum lipid composition.

Clinical evidence — some ceramide products (particularly those used in dermatology for atopic dermatitis) have published clinical data. Products with published, independent clinical evidence are more credible than those relying solely on ingredient-level research.

The ceramide category is one of the most legitimate in skincare — the ingredient works, the mechanism is well-understood, and the clinical evidence is strong. The problem is not the ingredient. The problem is that many products use ceramides as a marketing claim while formulating with concentrations that are unlikely to provide meaningful barrier support.

Reading the INCI list carefully — looking at which ceramides are present, how many, and where they appear in the list — is the most reliable way to evaluate whether a ceramide product is likely to deliver on its claims.